GRIFOLS reported EUR680.41M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Alcon AG USD 20M 0 Mar/2025
Almirall EUR 214.79M 189.17M Jun/2025
Amadeus IT EUR 442.98M 438.48M Jun/2025
Amarin USD 308.15M 2.85M Mar/2025
argenx SE 61.17M 405.3K Jun/2025
AstraZeneca USD 1.55B 1.16B Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Cie Automotive EUR 29.95M 0 Dec/2024
Demant DKK 205.72M 161.72M Jun/2025
Ence Energia y Celulosa 242.42M 20.78M Jun/2025
Essilor EUR 456.71M 374.71M Jun/2025
Ferrovial EUR 7M 0 Dec/2024
Fresenius EUR 563.24M 237K Jun/2025
Fresenius Medical Care EUR 293.41M 0 Jun/2025
Galapagos EUR 65.9M 228.04M Jun/2025
Genmab DKK 10M 56M Mar/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
GRIFOLS EUR 680.41M 560.8M Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Merck EUR 434.78M 130.22M Jun/2025
Novartis USD 793M 0 Dec/2024
Philips EUR 950.57M 762.57M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Sanofi 1.22B 36.5M Jun/2025
Smith & Nephew USD 875.96M 700.96M Jun/2025
UCB EUR 584M 0 Dec/2024
Viscofan EUR 47.17M 14.62M Jun/2025